ALPS: An autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis

Seminars in Immunology

Volumn 9, Issue 1, 1997, Pages 77-84

  Puck, Jennifer M ^a   Sneller, Michael C ^b  

^a National Human Genomics Research Institute   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Complex genetic trait; Fas gene; Human mutation; Immune regulation; Lymphocyte homeostasis; Programmed cell death

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; FAS ANTIGEN;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; T LYMPHOCYTE;

EID: 0031080703     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0056     Document Type: Article

References (28)

1. 1. Lenardo M (1996) Fas and the art of lymphocyte maintenance. J Exp Med 183:721
2. 2. Lenardo MJ (1991) Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858-862
3. 3. Ju ST, Panka DJ, Cui H, Ettinger R, El KM, Sherr DH, Stanger BZ, Marshak RA (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
4. 4. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351
5. 5. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-318
6. 6. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976
7. 7. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH (1994) gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928-933
8. 8. Nagata S, Goldstein P (1995) The Fas death factor. Science 267:1449-1456
9. 9. Sneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler SM, Strober W (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334-341
10. 10. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villarty J (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349
11. 11. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
12. 12. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE (1997) Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood, in Press
13. 13. Gerdes, J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. I Immunol 133:1710-1715
14. 14. Gutierrez RJ, Andreu JL, Revilla Y, Vinuela E, Martinez C (1990) Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus. Nature 346:271-274
15. 15. Mountz JD, Smith HR, Wilder RL, Reeves JP, Steinberg AD (1987) CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol 138:157-163
16. 2+ signal in individual human peripheral T cells. J Immunol 150:5338-5349
17. 17. Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. J Biol Chem 268:10932-10937
18. cg a novel mutant gene. Int Rev Immunol 11:193-210
19. 19. Shivakumar S, Tsokos G, Datta S (1989) T cell receptor alpha/ beta expressing double negative and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 143:103-112
20. 20. Schattner EJ. Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557-1565
21. 21. Garrone P, Neidhardt EM, Garcia E, Galibert L, van KC, Banchereau J (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265-1273
22. 22. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC (1995) CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181-184
23. 23. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP, a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell 81:513-523
24. 24. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D (1995) A novel protein that interacts with the death domain of Fas/ APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795-7798
25. 25. Enari M, Hug H, Nagata S (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81
26. 26. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze OK (1995) Requirement of an ICE/CED-3 protease for Fas/ APO-1-mediated apoptosis. Nature 375:81-83
27. 27. Perillo N, Pace K, Seilhamer J, Baum L (1995) Apoptosis of T cells mediated by galectin-1. Nature 378:736-739
28. 28. Hsu H, Xiong J, Goeddel D (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell 81:495-504